Blog Posts

Martin Angel: Elegant presentation by Sumanta K. Pal

Collage of Martin Angel and Sumanta K. Pal

Jan 29, 2024, 13:48

Martin Angel: Elegant presentation by Sumanta K. Pal

Martin Angel, Clinical Oncologist at the Institute of Alexander Fleming, shared a post on X/Twitter:

“Elegant presentation by Sumanta K. Pal about ‘What Can Other Disease Sites Teach Us About Practical Implications of Immune Checkpoint Inhibitors (ICI) in Urothelial Carcinoma.'”

Source: Martin Angel/X

cancer Immune Checkpoint Inhibitors (ICI) Institute of Alexander Fleming Martin Angel OncoDaily Oncology Sumanta K. Pal urothelial carcinoma

FDA Accepts NDA for Vepdegestrant in ESR1-Mutant ER+/HER2- Advanced Breast Cancer

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 12, 2025, 19:32

George Kumar: Half a Million Genomes - A Landmark in Precision Medicine

Voices

Aug 12, 2025, 19:12

St. Baldrick’s Thanks KBR for $50K Match and Ongoing Support Against Childhood Cancer

Voices

Aug 12, 2025, 19:07

Patrick Soon-Shiong: Promising NK Cell and Bioshield Breakthrough for Waldenstrom’s

Insight

Aug 12, 2025, 18:52

Veronica Salais Michaus: Strategies in Challenging Clinic Scenarios in LATAM

Career Updates

Aug 12, 2025, 18:42

Michelle Mollica Started a New Chapter as Associate Professor at the Medical University of South Carolina

Insight

Aug 12, 2025, 18:34

Donald McDonnell: Successful Drug Discovery Through Collaboration and Strong Fundamental Research

Science

Aug 12, 2025, 18:18

Anthony R. Sloan: Estrogen-Dependent Platelet PAR4 Signaling Shapes Immunity in Glioblastoma

Science

Aug 12, 2025, 17:56

Stephen V Liu: Early ctDNA Dynamics in SCLC Show Prognostic Value in TAZMAN Trial

Insight

Aug 12, 2025, 17:45

Zheng Wang: Clinicopathological and Molecular Characteristics of HER2-Low TNBC in Asian Women

Science

Aug 12, 2025, 17:40

Oscar Tahuahua: Triple M from ICIs

Science

Aug 12, 2025, 17:23

Mario Balsa: New Nature Reviews Cancer Article Dives Deep into SCLC

Insight

Aug 12, 2025, 17:01

Every Thread Counts: Youth Cancer Europe Reflects on UNTOLD Festival 2025